About this episode
An update on the use of aspirin in primary prevention of cardiovascular disease.
We will review three large trials published in 2018, the ARRIVE Trial, ASCEND Trial, and ASPREE Trial that compared risks vs. benefits of aspirin in a variety of different primary prevention populations. We will also explore new guideline recommendations as a result of this new evidence. Finally, I’ll try and summarize the impact this will have on practice and how I personally am changing the way I’m managing aspirin use.
We will review three large trials published in 2018, the ARRIVE Trial, ASCEND Trial, and ASPREE Trial that compared risks vs. benefits of aspirin in a variety of different primary prevention populations. We will also explore new guideline recommendations as a result of this new evidence. Finally, I’ll try and summarize the impact this will have on practice and how I personally am changing the way I’m managing aspirin use.
Get every episode summarized
Each time Ambulatory Care Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Ambulatory Care Podcast
Poster to Podcast: Highlighting the Project
Ambulatory Care Podcast
Jan 5, 202615:24pending
AHA/ACC Hypertension Guidelines
Ambulatory Care Podcast
Nov 24, 202539:23pending
PSW Member Spotlight - Rani Rajan
Ambulatory Care Podcast
Nov 4, 202511:56pending
2025 ADA Standards of Care Update
Ambulatory Care Podcast
May 16, 202527:28pending